{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:43:24Z","timestamp":1793385804266,"version":"4.5.0"},"reference-count":243,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology"],"abstract":"<jats:p>Cardiovascular diseases (CVDs) are the leading causes of death worldwide. Epicardial adipose tissue (EAT) is defined as a fat depot localized between the myocardial surface and the visceral layer of the pericardium and is a type of visceral fat. EAT is one of the most important risk factors for atherosclerosis and cardiovascular events and a promising new therapeutic target in CVDs. In health conditions, EAT has a protective function, including protection against hypothermia or mechanical stress, providing myocardial energy supply from free fatty acid and release of adiponectin. In patients with obesity, metabolic syndrome, or diabetes mellitus, EAT becomes a deleterious tissue promoting the development of CVDs. Previously, we showed an adverse modulation of gene expression in pericoronary adipose tissue in patients with coronary artery disease (CAD). Here, we summarize the currently available evidence regarding the role of EAT in the development of CVDs, including CAD, heart failure, and atrial fibrillation. Due to the rapid development of the COVID-19 pandemic, we also discuss data regarding the association between EAT and the course of COVID-19. Finally, we present the potential therapeutic possibilities aiming at modifying EAT\u2019s function. The development of novel therapies specifically targeting EAT could revolutionize the prognosis in CVDs.<\/jats:p>","DOI":"10.3390\/biology11030355","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T09:34:38Z","timestamp":1645608878000},"page":"355","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["Role of Epicardial Adipose Tissue in Cardiovascular Diseases: A Review"],"prefix":"10.3390","volume":"11","author":[{"given":"Micha\u0142","family":"Konwerski","sequence":"first","affiliation":[{"name":"1st Chair and Department of Cardiology, Medical University of Warsaw, 02-097 Warszawa, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5083-7587","authenticated-orcid":false,"given":"Aleksandra","family":"G\u0105secka","sequence":"additional","affiliation":[{"name":"1st Chair and Department of Cardiology, Medical University of Warsaw, 02-097 Warszawa, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4744-2554","authenticated-orcid":false,"given":"Grzegorz","family":"Opolski","sequence":"additional","affiliation":[{"name":"1st Chair and Department of Cardiology, Medical University of Warsaw, 02-097 Warszawa, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3306-0301","authenticated-orcid":false,"given":"Marcin","family":"Grabowski","sequence":"additional","affiliation":[{"name":"1st Chair and Department of Cardiology, Medical University of Warsaw, 02-097 Warszawa, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3693-8741","authenticated-orcid":false,"given":"Tomasz","family":"Mazurek","sequence":"additional","affiliation":[{"name":"1st Chair and Department of Cardiology, Medical University of Warsaw, 02-097 Warszawa, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"ref_2","first-page":"1","article-title":"Deaths: Leading Causes for 2013","volume":"68","author":"Heron","year":"2016","journal-title":"Natl. Vital Stat. Rep."},{"key":"ref_3","first-page":"1","article-title":"Prevalence of Uncontrolled Risk Factors for Cardiovascular Disease: United States, 1999\u20132010","volume":"103","author":"Fryar","year":"2012","journal-title":"NCHS Data Brief."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.ahj.2007.03.019","article-title":"Human epicardial adipose tissue: A review","volume":"153","author":"Sacks","year":"2007","journal-title":"Am. Heart J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.biocel.2007.12.001","article-title":"Visceral obesity and the heart","volume":"40","author":"Mathieu","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/clpt.2009.311","article-title":"Obesity, Inflammation, and Cardiovascular Risk","volume":"87","author":"Mathieu","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05488","article-title":"Abdominal obesity and metabolic syndrome","volume":"444","author":"Lemieux","year":"2006","journal-title":"Nature"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1467-789X.2006.00293.x","article-title":"Epicardial fat: Properties, function and relationship to obesity","volume":"8","author":"Rabkin","year":"2007","journal-title":"Obes. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/oby.2008.6","article-title":"Threshold values of high-risk echocardiographic epicardial fat thickness","volume":"16","author":"Iacobellis","year":"2008","journal-title":"Obesity"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jacc.2012.11.062","article-title":"Association of Epicardial Fat with Cardiovascular Risk Factors and Incident Myocardial Infarction in the General Population","volume":"61","author":"Mahabadi","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/07315724.2014.933685","article-title":"Pericoronary Adipose Tissue: A Novel Therapeutic Target in Obesity-Related Coronary Atherosclerosis","volume":"34","author":"Mazurek","year":"2015","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5604\/20831862.1198626","article-title":"High intensity interval and moderate continuous cycle training in a physical education programme improves health-related fitness in young females","volume":"33","author":"Mazurek","year":"2016","journal-title":"Biol. Sport"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"864","DOI":"10.5114\/aoms.2016.63259","article-title":"Clinical importance of epicardial adipose tissue","volume":"4","author":"Nagy","year":"2017","journal-title":"Arch. Med Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/01.CIR.0000080378.96063.23","article-title":"Diabetes-Induced Oxidative Stress and Low-Grade Inflammation in Porcine Coronary Arteries","volume":"108","author":"Zhang","year":"2003","journal-title":"Circulation"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/oby.21059","article-title":"Epicardial adipose tissue has a unique transcriptome modified in severe coronary artery disease","volume":"23","author":"McAninch","year":"2015","journal-title":"Obesity"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nrendo.2015.58","article-title":"Local and systemic effects of the multifaceted epicardial adipose tissue depot","volume":"11","author":"Iacobellis","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1161\/01.CIR.0000099542.57313.C5","article-title":"Human Epicardial Adipose Tissue Is a Source of Inflammatory Mediators","volume":"108","author":"Mazurek","year":"2003","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1210\/jc.2009-0571","article-title":"Uncoupling Protein-1 and Related Messenger Ribonucleic Acids in Human Epicardial and Other Adipose Tissues: Epicardial Fat Functioning as Brown Fat","volume":"94","author":"Sacks","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0195-668X(02)00426-8","article-title":"Eccentric atherosclerotic plaques with positive remodelling have a pericardial distribution: A permissive role of epicardial fat? A three-dimensional intravascular ultrasound study of left anterior descending artery lesions","volume":"24","author":"Prati","year":"2003","journal-title":"Eur. Heart J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.tem.2011.07.003","article-title":"Epicardial adipose tissue: Emerging physiological, pathophysiological and clinical features","volume":"22","author":"Iacobellis","year":"2011","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.numecd.2009.08.011","article-title":"Metabolic toxicity of the heart: Insights from molecular imaging","volume":"20","author":"Iozzo","year":"2010","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_22","first-page":"E1703","article-title":"Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative\/nitrative stress and differential regulation of eNOS\/iNOS activity","volume":"293","author":"Li","year":"2007","journal-title":"Am. J. Physiol. Metab."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ijo.2009.205","article-title":"Adiponectin directly improves endothelial dysfunction in obese rats through the AMPK-eNOS pathway","volume":"34","author":"Deng","year":"2010","journal-title":"Int. J. Obes."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"154981","DOI":"10.1016\/j.cyto.2019.154981","article-title":"Adiponectin promotes ischemic heart preconditioning-PRO and CON","volume":"127","author":"Niedziela","year":"2020","journal-title":"Cytokine"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.2147\/JIR.S326769","article-title":"Atherosclerosis Pathways are Activated in Pericoronary Adipose Tissue of Patients with Coronary Artery Disease","volume":"14","author":"Konwerski","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cyto.2008.05.006","article-title":"Extension of coronary artery disease is associated with increased IL-6 and decreased adiponectin gene expression in epicardial adipose tissue","volume":"43","author":"Eiras","year":"2008","journal-title":"Cytokine"},{"key":"ref_27","first-page":"251","article-title":"Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease","volume":"29","author":"Iacobellis","year":"2005","journal-title":"Cytokine"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Raman, P., and Khanal, S. (2021). Leptin in Atherosclerosis: Focus on Macrophages, Endothelial and Smooth Muscle Cells. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115446"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.biocel.2011.09.006","article-title":"Epicardial fat: From the biomolecular aspects to the clinical practice","volume":"43","author":"Iacobellis","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","article-title":"Immunity and Inflammation in Atherosclerosis","volume":"124","author":"Wolf","year":"2019","journal-title":"Circ. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"C13","DOI":"10.1016\/j.jacc.2005.10.065","article-title":"Pathology of the vulnerable plaque","volume":"47","author":"Virmani","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.carpath.2009.02.001","article-title":"Adventitial lymphocytic inflammation in human coronary arteries with intimal atherosclerosis","volume":"19","author":"Tavora","year":"2010","journal-title":"Cardiovasc. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1365-2265.2008.03411.x","article-title":"Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis","volume":"70","author":"Wang","year":"2009","journal-title":"Clin. Endocrinol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/CIRCULATIONAHA.107.743062","article-title":"Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: The Framingham Heart Study","volume":"117","author":"Rosito","year":"2008","journal-title":"Circulation"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.atherosclerosis.2009.11.020","article-title":"Epicardial adipose tissue and coronary artery plaque characteristics","volume":"210","author":"Alexopoulos","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1536\/ihj.17-709","article-title":"Association of Epicardial Adipose Tissue Volume and Total Coronary Plaque Burden in Patients with Coronary Artery Disease","volume":"59","author":"Yamashita","year":"2018","journal-title":"Int. Heart J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"410","DOI":"10.5603\/KP.a2013.0320","article-title":"Inflammatory activity of pericoronary adipose tissue may affect plaque composition in patients with acute coronary syndrome without persistent ST-segment elevation: Preliminary results","volume":"72","author":"Mazurek","year":"2013","journal-title":"Kardiol. Pol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s12350-015-0370-6","article-title":"PET\/CT evaluation of 18F-FDG uptake in pericoronary adipose tissue in patients with stable coronary artery disease: Independent predictor of atherosclerotic lesions\u2019 formation?","volume":"24","author":"Mazurek","year":"2016","journal-title":"J. Nucl. Cardiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00059-013-3914-z","article-title":"Association of epicardial fat thickness with TIMI risk score in NSTEMI\/USAP patients","volume":"39","author":"Turak","year":"2014","journal-title":"Herz"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"ehab724-0208","DOI":"10.1093\/eurheartj\/ehab724.0208","article-title":"Epicardial adipose tissue volume is associated with low-attenuation plaque volume in subjects with or without increased visceral fat: A 3-vessel coronary artery analysis with CT angiography","volume":"42","author":"Otsuka","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"7251","DOI":"10.1007\/s00330-021-07882-1","article-title":"Focal pericoronary adipose tissue attenuation is related to plaque presence, plaque type, and stenosis severity in coronary CTA","volume":"31","author":"Ma","year":"2021","journal-title":"Eur. Radiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.atherosclerosis.2018.05.035","article-title":"Pericoronary fat volume but not attenuation differentiates culprit lesions in patients with myocardial infarction","volume":"276","author":"Balcer","year":"2018","journal-title":"Atherosclerosis"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/jamacardio.2018.1997","article-title":"Pericoronary Adipose Tissue Computed Tomography Attenuation and High-Risk Plaque Characteristics in Acute Coronary Syndrome Compared with Stable Coronary Artery Disease","volume":"3","author":"Goeller","year":"2018","journal-title":"JAMA Cardiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/ehjci\/jez013","article-title":"Relationship between changes in pericoronary adipose tissue attenuation and coronary plaque burden quantified from coronary computed tomography angiography","volume":"20","author":"Goeller","year":"2019","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"B98","DOI":"10.1016\/j.jacc.2021.09.1094","article-title":"TCT-241 Pericoronary Adipose Tissue Is a Predictor of In-Stent Restenosis and Stent Failure in Patients Undergoing Coronary Artery Stent Insertion","volume":"78 (19 Suppl. S)","author":"Nogic","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.atherosclerosis.2008.09.038","article-title":"Relation between epicardial fat thickness and coronary flow reserve in women with chest pain and angiographically normal coronary arteries","volume":"204","author":"Sade","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0735-1097(21)02791-1","article-title":"The impact of pericoronary adipose tissue attenuation on global coronary flow reserve in patients with stable coronary artery disease","volume":"77","author":"Kanaji","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2021.05.040","article-title":"Human coronary inflammation by computed tomography: Relationship with coronary microvascular dysfunction","volume":"336","author":"Pasqualetto","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2020.09.074","article-title":"Relationship between epicardial adipose tissue volume and coronary artery spasm","volume":"324","author":"Kataoka","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1080\/21623945.2019.1701387","article-title":"Relationship between epicardial adipose tissue thickness and epicardial adipocyte size with increasing body mass index","volume":"8","author":"Moharram","year":"2019","journal-title":"Adipocyte"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Naryzhnaya, N.V., Koshelskaya, O.A., Kologrivova, I.V., Kharitonova, O.A., Evtushenko, V.V., and Boshchenko, A.A. (2021). Hypertrophy and Insulin Resistance of Epicardial Adipose Tissue Adipocytes: Association with the Coronary Artery Disease Severity. Biomedicines, 9.","DOI":"10.3390\/biomedicines9010064"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cpcardiol.2015.12.002","article-title":"Heart failure with preserved ejection fraction","volume":"41","author":"Reddy","year":"2016","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCULATIONAHA.116.021884","article-title":"Phenotype-specific treatment of heart failure with preserved ejection fraction: A multiorgan roadmap","volume":"134","author":"Shah","year":"2016","journal-title":"Circulation"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2016.05.019","article-title":"The HFpEF obesity phenotype: The elephant in the room","volume":"68","author":"Kitzman","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jchf.2018.05.018","article-title":"The Association of Obesity and Cardiometabolic Traits with Incident HFpEF and HFrEF","volume":"6","author":"Savji","year":"2018","journal-title":"JACC Heart Fail."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.amjcard.2014.08.037","article-title":"Influence of epicardial and visceral fat on left ventricular diastolic and systolic functions inpatients after myocardial infarction","volume":"114","author":"Sampaio","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2337\/dc10-1312","article-title":"Pericardial fat and echocardiographic measures of cardiac abnormalities: The Jackson Heart Study","volume":"34","author":"Liu","year":"2011","journal-title":"Diabetes Care"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.amjcard.2012.07.045","article-title":"Association of Epicardial Fat, Hypertension, Subclinical Coronary Artery Disease, and Metabolic Syndrome with Left Ventricular Diastolic Dysfunction","volume":"110","author":"Cavalcante","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e009975","DOI":"10.1161\/JAHA.118.009975","article-title":"Association of Volumetric Epicardial Adipose Tissue Quantification and Cardiac Structure and Function","volume":"7","author":"Nerlekar","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","article-title":"Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure with Preserved Ejection Fraction","volume":"136","author":"Obokata","year":"2017","journal-title":"Circulation"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1161\/01.CIR.0000127959.28627.F8","article-title":"Effect of Obesity and Insulin Resistance on Myocardial Substrate Metabolism and Efficiency in Young Women","volume":"109","author":"Peterson","year":"2004","journal-title":"Circulation"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/ncpcardio0319","article-title":"Epicardial adipose tissue: Anatomic, biomolecular and clinical relationships with the heart","volume":"2","author":"Iacobellis","year":"2005","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jchf.2020.04.016","article-title":"Hemodynamic and Functional Impact of Epicardial Adipose Tissue in Heart Failure with Preserved Ejection Fraction","volume":"8","author":"Koepp","year":"2020","journal-title":"JACC Heart Fail."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/ejhf.1283","article-title":"Epicardial fat in heart failure patients with mid-range and preserved ejection fraction","volume":"20","author":"Gorter","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.tcm.2014.09.005","article-title":"Impact of obesity on cardiac metabolism, fibrosis, and function","volume":"25","author":"Mahajan","year":"2015","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCULATIONAHA.114.009625","article-title":"Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction","volume":"131","author":"Mohammed","year":"2015","journal-title":"Circulation"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e005277","DOI":"10.1161\/CIRCIMAGING.116.005277","article-title":"Interstitial fibrosis, functional status, and outcomes in heart failure with preserved ejection fraction: Insights from a prospective cardiac magnetic resonance imaging study","volume":"9","author":"Duca","year":"2016","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.jacc.2018.03.509","article-title":"Epicardial Adipose Tissue May Mediate Deleterious Effects of Obesity and Inflammation on the Myocardium","volume":"71","author":"Packer","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e007372","DOI":"10.1161\/CIRCIMAGING.117.007372","article-title":"Impact of epicardial adipose tissue, left ventricular myocardial fat content, and interstitial fibrosis on myocardial contractile function","volume":"11","author":"Ng","year":"2018","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e008083","DOI":"10.1161\/CIRCIMAGING.118.008083","article-title":"Cardiac Magnetic Resonance Imaging of Epicardial and Intramyocardial Adiposity as an Early Sign of Myocardial Disease","volume":"11","author":"Antonopoulos","year":"2018","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1532-429X-15-103","article-title":"Cardiac steatosis and left ventricular function in men with metabolic syndrome","volume":"15","author":"Nyman","year":"2013","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cjca.2017.08.001","article-title":"Relationships Between Periventricular Epicardial Adipose Tissue Accumulation, Coronary Microcirculation, and Left Ventricular Diastolic Dysfunction","volume":"33","author":"Nakanishi","year":"2017","journal-title":"Can. J. Cardiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.cjca.2017.08.013","article-title":"Is reduction in coronary blood flow themechanism by which epicardial fat produces left ventricular diastolic dysfunction?","volume":"33","author":"Rabkin","year":"2017","journal-title":"Can. J. Cardiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"ehab724-0820","DOI":"10.1093\/eurheartj\/ehab724.0820","article-title":"Prognostic significance of epicardial adipose tissue in heart failure with preserved and reduced ejection fraction","volume":"42","author":"Pugliese","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Nyawo, T.A., Dludla, P.V., Mazibuko-Mbeje, S.E., Mthembu, S.X.H., Nyambuya, T.M., Nkambule, B.B., Gijsen, H.S.-V., Strijdom, H., and Pheiffer, C. (2021). A systematic review exploring the significance of measuring epicardial fat thickness in correlation to B-type natriuretic peptide levels as prognostic and diagnostic markers in patients with or at risk of heart failure. Heart Fail. Rev., 1\u201311.","DOI":"10.1007\/s10741-021-10160-3"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e13070","DOI":"10.1111\/ijcp.13070","article-title":"Epidemiology of atrial fibrillation","volume":"72","author":"Zulkifly","year":"2018","journal-title":"Int. J. Clin. Pract."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.jacc.2010.01.043","article-title":"Prevention of Atrial Fibrillation by Renin-Angiotensin System Inhibition: A Meta-Analysis","volume":"55","author":"Schneider","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1010-7940(96)01012-3","article-title":"Spontaneous cardioversion and mitral valve repair: A role for surgical cardioversion (Cox-maze)?","volume":"11","author":"Large","year":"1997","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/j.jacc.2015.03.557","article-title":"Fibrotic atrial cardiomyo-pathy, atrial fibrillation, and thromboembolism: Mechanistic links and clinical inferences","volume":"65","author":"Hirsh","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00380-004-0800-x","article-title":"C-Reactive protein elevation predicts the occurrence of atrial structural remodeling in patients with paroxysmal atrial fibrillation","volume":"20","author":"Watanabe","year":"2005","journal-title":"Heart Vessel."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e1257","DOI":"10.1136\/bmj.e1257","article-title":"Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study","volume":"344","author":"Lindhardsen","year":"2012","journal-title":"BMJ"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"9973","DOI":"10.1038\/s41598-017-10556-y","article-title":"Increased Risk of Atrial Fibrillation and Thromboembolism in Patients with Severe Psoriasis: A Nationwide Population-based Study","volume":"7","author":"Rhee","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_83","first-page":"2185","article-title":"Non-invasive electrocardiographic methods for assessment of atrial conduction heterogeneity in ankylosing spondylitis","volume":"20","author":"Aksoy","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/echo.13261","article-title":"Atrial Electromechanical Properties in Inflammatory Bowel Disease","volume":"33","author":"Efe","year":"2016","journal-title":"Echocardiography"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ahj.2007.10.004","article-title":"Atrial fibrillation and obesity\u2014Results of a meta-analysis","volume":"155","author":"Wanahita","year":"2008","journal-title":"Am. Heart J."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/heartjnl-2011-300503","article-title":"Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: The Atherosclerosis Risk in Communities study","volume":"98","author":"Huxley","year":"2011","journal-title":"Heart"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1007\/s00330-014-3299-2","article-title":"Left atrial dysfunction in type 2 diabetes mellitus: Insights from cardiac MRI","volume":"24","author":"Ferreira","year":"2014","journal-title":"Eur. Radiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.numecd.2018.02.008","article-title":"Metabolic syndrome associates with left atrial dysfunction","volume":"28","author":"Nyman","year":"2018","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"15566","DOI":"10.1038\/s41598-017-15501-7","article-title":"Functional characterization of the Ucp1-associated oxidative phenotype of human epicardial adipose tissue","volume":"7","author":"Chechi","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/met.2008.0056","article-title":"Fatty acid composition of epicardial and subcutaneous human adipose tissue","volume":"7","author":"Pezeshkian","year":"2009","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejcts.2010.05.006","article-title":"Protective effect of epicardial adiponectin on atrial fibrillation following cardiac surgery","volume":"39","author":"Kourliouros","year":"2011","journal-title":"Eur. J. Cardio-Thoracic. Surg."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1113\/EP086407","article-title":"Heart-bound adiponectin, not serum adiponectin, inversely correlates with cardiac hypertrophy in stroke-prone spontaneously hypertensive rats","volume":"102","author":"Inoue","year":"2017","journal-title":"Exp. Physiol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1161\/CIRCRESAHA.115.307856","article-title":"Mutual regulation of epicardial adipose tissue and myocardial redox state by PPARgamma\/adiponectin signalling","volume":"118","author":"Antonopoulos","year":"2016","journal-title":"Circ Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"R229","DOI":"10.1186\/ar4070","article-title":"The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: Novel target for fibrosis therapy","volume":"14","author":"Fang","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.carpath.2008.02.006","article-title":"Presence of fatty-acid-binding protein 4 expression in human epicardial adipose tissue in metabolic syndrome","volume":"17","author":"Vural","year":"2008","journal-title":"Cardiovasc. Pathol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4070\/kcj.2012.42.7.471","article-title":"Correlation Between Epicardial Fat Thickness by Echocardiography and Other Parameters in Obese Adolescents","volume":"42","author":"Kim","year":"2012","journal-title":"Korean Circ. J."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/ATVBAHA.110.204719","article-title":"Epicardial Adipokines in Obesity and Coronary Artery Disease Induce Atherogenic Changes in Monocytes and Endothelial Cells","volume":"30","author":"Karastergiou","year":"2010","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00380-012-0315-9","article-title":"Inflammatory profile in subcutaneous and epicardial adipose tissue in men with and without diabetes","volume":"29","author":"Bambace","year":"2014","journal-title":"Heart Vessel."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/sj.ijo.0803726","article-title":"Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease","volume":"32","author":"Cheng","year":"2008","journal-title":"Int. J. Obes."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.amjcard.2014.02.005","article-title":"Relation of Proinflammatory Activity of Epicardial Adipose Tissue to the Occurrence of Atrial Fibrillation","volume":"113","author":"Mazurek","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3389\/fphys.2016.00313","article-title":"Reactive oxygen species, endoplasmic reticulum stress and mitochondrial dysfunction: The link with cardiac arrhythmogenesis","volume":"7","author":"Tse","year":"2016","journal-title":"Front. Physiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jacc.2007.07.085","article-title":"Association of Atrial Nicotinamide Adenine Dinucleotide Phosphate Oxidase Activity With the Development of Atrial Fibrillation After Cardiac Surgery","volume":"51","author":"Kim","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"H202","DOI":"10.1152\/ajpheart.00120.2010","article-title":"Proteomic analysis of epicardial and subcutaneous adipose tissue reveals differences in proteins involved in oxidative stress","volume":"299","author":"Eiras","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/eurheartj\/ehv625","article-title":"Atrial fibrillation is associated with the fibrotic remodelling of adipose tissue in the subepicardium of human and sheep atria","volume":"38","author":"Haemers","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.jacc.2011.05.061","article-title":"Structural Abnormalities in Atrial Walls Are Associated with Presence and Persistency of Atrial Fibrillation But Not with Age","volume":"58","author":"Platonov","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e000477","DOI":"10.1161\/JAHA.113.000477","article-title":"Pericardial Fat is Associated with Atrial Conduction: The Framingham Heart Study","volume":"3","author":"Friedman","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/pace.13825","article-title":"Epicardial adipose tissue and atrial fibrillation: Possible mechanisms, potential therapies, and future directions","volume":"43","author":"Zhou","year":"2019","journal-title":"Pacing Clin. Electrophysiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jjcc.2014.12.006","article-title":"Computed tomography angiography for prediction of atrial fibrillation after coronary artery bypass grafting: Proof of concept","volume":"65","author":"Opolski","year":"2015","journal-title":"J. Cardiol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1161\/CIRCULATIONAHA.111.018028","article-title":"Continuous Low-Level Vagus Nerve Stimulation Reduces Stellate Ganglion Nerve Activity and Paroxysmal Atrial Tachyarrhythmias in Ambulatory Canines","volume":"123","author":"Shen","year":"2011","journal-title":"Circulation"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/CIRCRESAHA.114.303772","article-title":"Role of the autonomic nervous system in atrial fibrillation: Pathophysiology and therapy","volume":"114","author":"Chen","year":"2014","journal-title":"Circ Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/pace.12512","article-title":"Arrhythmogenic Evidence for Epicardial Adipose Tissue: Heart Rate Variability and Turbulence are Influenced by Epicardial Fat Thickness","volume":"38","author":"Akinci","year":"2015","journal-title":"Pacing Clin. Electrophysiol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.amjcard.2008.04.064","article-title":"Evaluation of Catheter Ablation of Periatrial Ganglionic Plexi in Patients with Atrial Fibrillation","volume":"102","author":"Danik","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/CIRCEP.112.972224","article-title":"Effects of postmenopausal hormone therapy on incident atrial fibrillation: TheWomen\u2019s health initiative randomized controlled trials","volume":"5","author":"Perez","year":"2012","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.yjmcc.2017.08.006","article-title":"Pericardial adipose and aromatase: A new translational target for aging, obesity and arrhythmogenesis?","volume":"111","author":"Bernasochi","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.jacc.2021.08.037","article-title":"Modulation of Cardiac Arrhythmogenesis by Epicardial Adipose Tissue: JACC State-of-the-Art Review","volume":"78","author":"Ernault","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jacep.2015.04.004","article-title":"Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: A metaanalysis of 626,603 individuals in 51 studies","volume":"1","author":"Wong","year":"2015","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1161\/CIRCEP.109.912055","article-title":"Pericardial fat is associated with prevalent atrial fibrillation: The Framingham heart study","volume":"3","author":"Thanassoulis","year":"2010","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jacc.2010.03.071","article-title":"Pericardial fat is independently associated with human atrial fibrillation","volume":"56","author":"Welles","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/CIRCEP.110.957241","article-title":"Left Atrial Epicardial Adiposity and Atrial Fibrillation","volume":"3","author":"Batal","year":"2010","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1536\/ihj.54.297","article-title":"Epicardial Adipose Tissue Is Associated With Prevalent Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy","volume":"54","author":"Muhib","year":"2013","journal-title":"Int. Heart J."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.jacc.2010.11.045","article-title":"Pericardial Fat Is Associated with Atrial Fibrillation Severity and Ablation Outcome","volume":"57","author":"Wong","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.amjcard.2011.01.027","article-title":"Quantitative Analysis of Quantity and Distribution of Epicardial Adipose Tissue Surrounding the Left Atrium in Patients with Atrial Fibrillation and Effect of Recurrence after Ablation","volume":"107","author":"Tsao","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e004378","DOI":"10.1161\/CIRCEP.116.004378","article-title":"Associations of Epicardial, Abdominal, and Overall Adiposity with Atrial Fibrillation","volume":"9","author":"Wong","year":"2016","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/europace\/euw398","article-title":"Is epicardial fat depot associated with atrial fibrillation? A systematic review and meta-analysis","volume":"19","author":"Gaeta","year":"2017","journal-title":"Europace"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3389\/fmed.2020.00301","article-title":"Immune-Inflammatory Parameters in COVID-19 Cases: A Systematic Review and Meta-Analysis","volume":"7","author":"Feng","year":"2020","journal-title":"Front. Med."},{"key":"ref_127","first-page":"485","article-title":"Impaired microcirculation function in COVID-19 and implications for potential therapies","volume":"27","author":"Filipiak","year":"2020","journal-title":"Cardiol. J."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cca.2020.06.012","article-title":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in COVID-19 patients","volume":"509","author":"Poggiali","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"217","DOI":"10.33963\/KP.15830","article-title":"D-dimer levels predict COVID-19 severity and mortality","volume":"79","author":"Ruetzler","year":"2021","journal-title":"Kardiol. Pol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"886","DOI":"10.5603\/CJ.a2020.0171","article-title":"Evidence of diagnostic value of ferritin in patients with COVID-19","volume":"27","author":"Szarpak","year":"2020","journal-title":"Cardiol. J."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"13083","DOI":"10.1111\/obr.13083","article-title":"Should patients with obesity be more afraid of COVID-19?","volume":"21","author":"Rychter","year":"2020","journal-title":"Obes. Rev."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/oby.22843","article-title":"Is Adipose Tissue a Reservoir for Viral Spread, Immune Activation, and Cytokine Amplification in Coronavirus Disease 2019?","volume":"28","author":"Ryan","year":"2020","journal-title":"Obesity"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"107174","DOI":"10.1016\/j.intimp.2020.107174","article-title":"Epicardial adipose tissue, inflammatory biomarkers and COVID-19: Is there a possible relationship?","volume":"90","author":"Abrishami","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/oby.22943","article-title":"Obesity as a Potential Predictor of Disease Severity in Young COVID-19 Patients: A Retrospective Study","volume":"28","author":"Deng","year":"2020","journal-title":"Obesity"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/oby.23019","article-title":"Epicardial Fat Inflammation in Severe COVID-19","volume":"28","author":"Iacobellis","year":"2020","journal-title":"Obesity"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"154436","DOI":"10.1016\/j.metabol.2020.154436","article-title":"Epicardial adipose tissue is associated with extent of pneumonia and adverse outcomes in patients with COVID-19","volume":"115","author":"Grodecki","year":"2021","journal-title":"Metabolism"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/ejhf.1967","article-title":"Pathogenesis and management of myocardial injury in coronavirus disease 2019","volume":"22","author":"Wei","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"107228","DOI":"10.1016\/j.carpath.2020.107228","article-title":"Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019","volume":"47","author":"Geng","year":"2020","journal-title":"Cardiovasc. Pathol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10557-020-07084-9","article-title":"Thrombotic Complications in Patients with COVID-19: Pathophysiological Mechanisms, Diagnosis, and Treatment","volume":"35","author":"Borovac","year":"2021","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Szarpak, L., Filipiak, K.J., Skwarek, A., Pruc, M., Rahnama, M., Denegri, A., Jachowicz, M., Dawidowska, M., Gasecka, A., and Jaguszewski, M.J. (2021). Outcomes and mortality associated with atrial arrhythmias among patients hospitalized with COVID-19: A systematic review and meta-analysis. Cardiol. J.","DOI":"10.5603\/CJ.a2021.0167"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Nucera, G., Chirico, F., Rafique, Z., Gilis-Malinowska, N., Gasecka, A., Litvinova, N., Wang, B., Ilesanmi, O., Pruc, M., and Jaguszewski, M.J. (2021). Need to update cardiological guidelines to prevent COVID-19 related myocardial infarction and ischemic stroke. Cardiol. J.","DOI":"10.5603\/CJ.a2021.0120"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"353","DOI":"10.5603\/CJ.a2021.0028","article-title":"Post-COVID-19 heart syndrome","volume":"28","author":"Gasecka","year":"2021","journal-title":"Cardiol. J."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Hui, H., Zhang, Y., Yang, X., Wang, X., He, B., Li, L., Li, H., Tian, J., and Chen, Y. (2020). Clinical and radiographic features of cardiac injury in patients with 2019 novel coronavirus pneumonia. MedR\u03c7iv.","DOI":"10.1101\/2020.02.24.20027052"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"585220","DOI":"10.3389\/fcvm.2020.585220","article-title":"Pre-existing Health Conditions and Epicardial Adipose Tissue Volume: Potential Risk Factors for Myocardial Injury in COVID-19 Patients","volume":"7","author":"Wei","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"13136","DOI":"10.1111\/obr.13136","article-title":"Targeting epicardial adipose tissue with exercise, diet, bariatric surgery or pharmaceutical interventions: A systematic review and meta-analysis","volume":"22","author":"Launbo","year":"2021","journal-title":"Obes. Rev."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/obr.12270","article-title":"Comparison of reducing epicardial fat by exercise, diet or bariatric surgery weight loss strategies: A systematic review and meta-analysis","volume":"16","author":"Rabkin","year":"2015","journal-title":"Obes. Rev."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jamacardio.2019.2074","article-title":"Effect of Aerobic and Resistance Exercise on Cardiac Adipose Tissues: Secondary Analyses From a Randomized Clinical Trial","volume":"4","author":"Christensen","year":"2019","journal-title":"JAMA Cardiol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00421-018-3852-9","article-title":"Effects of resistance training on MRI-derived epicardial fat volume and arterial stiffness in women with obesity: A randomized pilot study","volume":"118","author":"Gonzales","year":"2018","journal-title":"Eur. J. Appl. Physiol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2015.12.015","article-title":"Effects of additional exercise training on epicardial, intra-abdominal and subcutaneous adipose tissue in major depressive disorder: A randomized pilot study","volume":"192","author":"Kahl","year":"2016","journal-title":"J. Affect. Disord."},{"key":"ref_150","first-page":"609","article-title":"A home-based treadmill training reduced epicardial and abdominal fat in postmenopausal women with metabolic syndrome","volume":"30","year":"2014","journal-title":"Nutr. Hosp."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Konwerski, M., Postu\u0142a, M., Barczuk-Fal\u0119cka, M., Czajkowska, A., Mr\u00f3z, A., Witek, K., Bakalarski, W., G\u0105secka, A., Ma\u0142ek, \u0141., and Mazurek, T. (2021). Epicardial Adipose Tissue and Cardiovascular Risk Assessment in Ultra-Marathon Runners: A Pilot Study. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18063136"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1161\/CIRCULATIONAHA.117.030501","article-title":"Effect of distinct lifestyle interventions on mobilization of fat storage pools CENTRAL magnetic resonance imaging randomized controlled trial","volume":"137","author":"Gepner","year":"2018","journal-title":"Circulation"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.numecd.2009.01.010","article-title":"Comparison of epicardial, abdominal and regional fat compartments in response to weight loss","volume":"19","author":"Kim","year":"2009","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1038\/oby.2011.390","article-title":"Long-Term Beneficial Effect of a 16-Week Very Low Calorie Diet on Pericardial Fat in Obese Type 2 Diabetes Mellitus Patients","volume":"20","author":"Snel","year":"2012","journal-title":"Obesity"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/oby.2008.251","article-title":"Substantial Changes in Epicardial Fat Thickness after Weight Loss in Severely Obese Subjects","volume":"16","author":"Iacobellis","year":"2008","journal-title":"Obesity"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.amjcard.2006.12.042","article-title":"Effects of Weight Loss after Bariatric Surgery on Epicardial Fat Measured Using Echocardiography","volume":"99","author":"Willens","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.jacc.2012.06.016","article-title":"Effects of bariatric surgery on cardiac ectopic fat: Lesser decrease in epicardial fat compared to visceral fat loss and no change in myocardial triglyceride content","volume":"60","author":"Gaborit","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/dom.13183","article-title":"Reversibility of myocardial metabolism and remodelling in morbidly obese patients 6 months after bariatric surgery","volume":"20","author":"Hannukainen","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1016\/j.ijcard.2013.04.202","article-title":"Effects of bariatric surgery on cardiac remodeling: Clinical and pathophysiologic implications","volume":"168","author":"Graziani","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/j.jacc.2012.12.051","article-title":"Effect of intensive versus moderate lipid-lowering therapy on epicardial adipose tissue in hyperlipidemic post-menopausal women: A substudy of the BELLES trial (beyond endorsed lipid lowering with EBT scanning)","volume":"61","author":"Alexopoulos","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.amjcard.2015.07.067","article-title":"Effects of Atorvastatin (80 mg) Therapy on Quantity of Epicardial Adipose Tissue in Patients Undergoing Pulmonary Vein Isolation for Atrial Fibrillation","volume":"116","author":"Soucek","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijcard.2018.06.106","article-title":"Statin therapy modulates thickness and inflammatory profile of human epicardial adipose tissue","volume":"274","author":"Parisi","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"e013104","DOI":"10.1161\/JAHA.119.013104","article-title":"Statins Reduce Epicardial Adipose Tissue Attenuation Independent of Lipid Lowering: A Potential Pleiotropic Effect","volume":"8","author":"Raggi","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.tcm.2019.01.001","article-title":"Effect of statins on atherosclerotic plaque","volume":"29","author":"Almeida","year":"2019","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jacc.2013.04.066","article-title":"Intensification of Statin Therapy Results in a Rapid Reduction in Atherosclerotic Inflammation: Results of a Multicenter Fluorodeoxyglucose-Positron Emission Tomography\/Computed Tomography Feasibility Study","volume":"62","author":"Tawakol","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Yang, Q., Qi, X., Dang, Y., Li, Y., Song, X., and Hao, X. (2016). Effects of atorvastatin on atrial remodeling in a rabbit model of atrial fibrillation produced by rapid atrial pacing. BMC Cardiovasc. Disord., 16.","DOI":"10.1186\/s12872-016-0301-8"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.4238\/2013.September.10.5","article-title":"Effect of atorvastatin on left atrial function of patients with paroxysmal atrial fibrillation","volume":"12","author":"Li","year":"2013","journal-title":"Genet. Mol. Res."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jacc.2007.09.063","article-title":"Antiarrhythmic Effect of Statin Therapy and Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials","volume":"51","author":"Fauchier","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1365-2125.2012.04258.x","article-title":"The role of statin therapy in the prevention of atrial fibrillation: A meta-analysis of randomized controlled trials","volume":"74","author":"Fang","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijcard.2007.07.137","article-title":"Statin use and development of atrial fibrillation: A systematic review and meta-analysis of randomized clinical trials and observational studies","volume":"126","author":"Liu","year":"2008","journal-title":"Int. J. Cardiol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1097\/HJH.0000000000000184","article-title":"Atorvastatin ameliorates cardiac fibrosis and improves left ventricular diastolic function in hypertensive diastolic heart failure model rats","volume":"32","author":"Akahori","year":"2014","journal-title":"J. Hypertens."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/eurjhf\/hfq101","article-title":"Rosuvastatin added to standard heart failure therapy improves cardiac remodelling in heart failure rats with preserved ejection fraction","volume":"12","author":"Aragoncillo","year":"2010","journal-title":"Eur. J. Heart Fail."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.atherosclerosis.2012.03.030","article-title":"Diastolic function parameters are improved by the addition of simvastatin to enalapril-based treatment in hypertensive individuals","volume":"222","author":"Beck","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2169\/internalmedicine.46.0021","article-title":"Impact of Statin Therapy on Systemic Inflammation, Left Ventricular Systolic and Diastolic Function and Prognosis in Low Risk Ischemic Heart Disease Patients without History of Congestive Heart Failure","volume":"46","author":"Okura","year":"2007","journal-title":"Intern. Med."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/eurheartj\/ehv072","article-title":"The effect of statin therapy on heart failure events: A collaborative meta-analysis of unpublished data from major randomized trials","volume":"36","author":"Preiss","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1253\/circj.CJ-18-0639","article-title":"Effect of Statins on Mortality in Heart Failure with Preserved Ejection Fraction without Coronary Artery Disease\u2015Report from the JASPER Study","volume":"83","author":"Marume","year":"2019","journal-title":"Circ. J."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.amjcard.2018.04.027","article-title":"Comparison of Effects of Statin Use on Mortality in Patients with Heart Failure and Preserved versus Reduced Left Ventricular Ejection Fraction","volume":"122","author":"Lee","year":"2018","journal-title":"Am. J. Cardiol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.amjcard.2013.12.023","article-title":"Meta-analysis of the effect of statins on mortality in patients with preserved ejection fraction","volume":"113","author":"Liu","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijcard.2016.03.186","article-title":"The effect of statins on mortality in heart failure with preserved ejection fraction: A meta-analysis of propensity score analyses","volume":"214","author":"Fukuta","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(08)61240-4","article-title":"Effect of rosuvastatin in patients with chronic heart failure (the GISSIHF trial): A randomised, double-blind, placebo-controlled trial","volume":"372","author":"Tavazzi","year":"2008","journal-title":"Lancet"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"ehaa946-3008","DOI":"10.1093\/ehjci\/ehaa946.3008","article-title":"Reduction of epicardial adipose tissue thickness with PCSK9 inhibitors","volume":"41","author":"Zelaya","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJMoa1506930","article-title":"Pioglitazone after Ischemic Stroke or Transient Ischemic Attack","volume":"374","author":"Kernan","year":"2016","journal-title":"New Engl. J. Med."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1093\/eurheartj\/ehz203","article-title":"A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: The MET-REMODEL trial","volume":"40","author":"Mohan","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Zhou, J., Massey, S., Story, D., and Li, L. (2018). Metformin: An Old Drug with New Applications. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19102863"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.mce.2017.09.025","article-title":"Metformin improves obesity-associated inflammation by altering macrophages polarization","volume":"461","author":"Jing","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"108025","DOI":"10.1016\/j.diabres.2020.108025","article-title":"Metformin: An old drug against old age and associated morbidities","volume":"160","author":"Salvatore","year":"2020","journal-title":"Diabetes Res. Clin. Pr."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"e000132","DOI":"10.1136\/esmoopen-2016-000132","article-title":"Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: A multicentre, open-label phase I\u2013II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer","volume":"2","author":"Morgillo","year":"2017","journal-title":"ESMO Open"},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Spencer, M., Yang, L., Adu, A., Finlin, B.S., Zhu, B., Shipp, L.R., Rasouli, N., Peterson, C.A., and Kern, P.A. (2014). Pioglitazone Treatment Reduces Adipose Tissue Inflammation through Reduction of Mast Cell and Macrophage Number and by Improving Vascularity. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0102190"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ijo.2017.192","article-title":"Role of adipocyte mitochondria in inflammation, lipemia and insulin sensitivity in humans: Effects of pioglitazone treatment","volume":"42","author":"Xie","year":"2018","journal-title":"Int. J. Obes."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/CIRCRESAHA.116.308445","article-title":"Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status","volume":"119","author":"Cameron","year":"2016","journal-title":"Circ. Res."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.repc.2018.08.010","article-title":"Metformin monotherapy significantly decreases epicardial adipose tissue thickness in newly diagnosed type 2 diabetes patients","volume":"38","author":"Ziyrek","year":"2019","journal-title":"Rev Port. Cardiol."},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Tokubuchi, I., Tajiri, Y., Iwata, S., Hara, K., Wada, N., Hashinaga, T., Nakayama, H., Mifune, H., and Yamada, K. (2017). Beneficial effects of metformin on energy metabolism and visceral fat volume through a possible mechanism of fatty acid oxidation in human subjects and rats. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0171293"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"9376","DOI":"10.7150\/thno.64706","article-title":"Metformin in cardiovascular diabetology: A focused review of its impact on endothelial function","volume":"11","author":"Ding","year":"2021","journal-title":"Theranostics"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1475-2840-12-150","article-title":"Activin a is associated with impaired myocardial glucose metabolism and left ventricular remodeling in patients with uncomplicated type 2 diabetes","volume":"12","author":"Chen","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-019-0931-0","article-title":"Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: Effects of metformin","volume":"18","author":"Sardu","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s40256-018-0266-3","article-title":"Cardioprotection by Metformin: Beneficial Effects Beyond Glucose Reduction","volume":"18","author":"Varjabedian","year":"2018","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10741-020-09987-z","article-title":"Pathogenesis of chronic heart failure: Cardiovascular aging, risk factors, comorbidities, and disease modifiers","volume":"27","author":"Triposkiadis","year":"2020","journal-title":"Hear. Fail. Rev."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"8633","DOI":"10.4049\/jimmunol.181.12.8633","article-title":"Adenosine 5\u2032-Monophosphate-Activated Protein Kinase Promotes Macrophage Polarization to an Anti-Inflammatory Functional Phenotype","volume":"181","author":"Sag","year":"2008","journal-title":"J. Immunol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ebiom.2017.05.028","article-title":"SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice","volume":"20","author":"Xu","year":"2017","journal-title":"EBioMedicine"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1007\/s00125-012-2592-3","article-title":"Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes","volume":"55","author":"Lee","year":"2012","journal-title":"Diabetologia"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vph.2017.03.003","article-title":"Teneligliptin, a dipeptidyl peptidase-4 inhibitor, attenuated pro-inflammatory phenotype of perivascular adipose tissue and inhibited atherogenesis in normoglycemic apolipoprotein-E-deficient mice","volume":"96-98","author":"Salim","year":"2017","journal-title":"Vasc. Pharmacol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1758-5996-6-47","article-title":"Synergistic antiinflammatory effect: Simvastatin and pioglitazone reduce inflammatory markers of plasma and epicardial adipose tissue of coronary patients with metabolic syndrome","volume":"6","author":"Grosso","year":"2014","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2337\/dc10-2083","article-title":"Inflammatory genes in epicardial fat contiguous with coronary atherosclerosis in the metabolic syndrome and type 2 diabetes: Changes associated with pioglitazone","volume":"34","author":"Sacks","year":"2011","journal-title":"Diabetes Care"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.biochi.2012.04.014","article-title":"Early induction of a brown-like phenotype by rosiglitazone in the epicardial adipose tissue of fatty Zucker rats","volume":"94","author":"Distel","year":"2012","journal-title":"Biochimie"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","article-title":"Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): A randomised controlled trial","volume":"366","author":"Dormandy","year":"2005","journal-title":"Lancet"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/jama.298.10.1180","article-title":"Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: A metaanalysis of randomized trials","volume":"298","author":"Lincoff","year":"2007","journal-title":"JAMA"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-017-0516-8","article-title":"Luseogliflozin reduces epicardial fat accumulation in patients with type 2 diabetes: A pilot study","volume":"16","author":"Bouchi","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s13300-017-0279-y","article-title":"Ipragliflozin Reduces Epicardial Fat Accumulation in Non-Obese Type 2 Diabetic Patients with Visceral Obesity: A Pilot Study","volume":"8","author":"Fukuda","year":"2017","journal-title":"Diabetes Ther."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.5551\/jat.48009","article-title":"The Effect of Dapagliflozin Treatment on Epicardial Adipose Tissue Volume and P-Wave Indices: An Ad-hoc Analysis of the Previous Randomized Clinical Trial","volume":"27","author":"Sato","year":"2020","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_212","doi-asserted-by":"crossref","unstructured":"Correale, M., Lamacchia, O., Ciccarelli, M., Dattilo, G., Tricarico, L., and Brunetti, N.D. (2021). Vascular and metabolic effects of SGLT2i and GLP-1 in heart failure patients. Heart Fail. Rev., 1\u201312.","DOI":"10.1007\/s10741-021-10157-y"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/STROKEAHA.120.031623","article-title":"Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results from the CREDENCE Trial and Meta-Analysis","volume":"52","author":"Zhou","year":"2021","journal-title":"Stroke"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1210\/jc.2011-2260","article-title":"Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin","volume":"97","author":"Bolinder","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/oby.22798","article-title":"Effects of Dapagliflozin on Epicardial Fat Thickness in Patients with Type 2 Diabetes and Obesity","volume":"28","author":"Iacobellis","year":"2020","journal-title":"Obesity"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/cvr\/cvx186","article-title":"Effects of dapagliflozin on human epicardial adipose tissue: Modulation of insulin resistance, inflammatory chemokine production, and differentiation ability","volume":"114","author":"Agra","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"ref_217","doi-asserted-by":"crossref","unstructured":"Masson, W., Lavalle-Cobo, A., and Nogueira, J.P. (2021). Effect of SGLT2-Inhibitors on Epicardial Adipose Tissue: A Meta-Analysis. Cells, 10.","DOI":"10.3390\/cells10082150"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/oby.21718","article-title":"Liraglutide causes large and rapid epicardial fat reduction","volume":"25","author":"Iacobellis","year":"2017","journal-title":"Obesity"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/dom.12680","article-title":"Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: A prospective randomized clinical trial using magnetic resonance imaging and spectroscopy","volume":"18","author":"Dutour","year":"2016","journal-title":"Diabetes Obes. Metab."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1042\/CS20160803","article-title":"GLP-1 analogue-induced weight loss does not improve obesity-induced AT dysfunction","volume":"131","author":"Pastel","year":"2017","journal-title":"Clin. Sci."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/oby.2000.38","article-title":"Central exendin-4 infusion reduces body weight without altering plasma leptin in (fa\/fa) Zucker rats","volume":"8","author":"Arch","year":"2000","journal-title":"Obes. Res."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jacbts.2018.09.004","article-title":"The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE-\/- and LDLr-\/- Mice by a Mechanism That Includes Inflammatory Pathways","volume":"3","author":"Rakipovski","year":"2018","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1055\/s-0043-109563","article-title":"Human Epicardial Fat Expresses Glucagon-Like Peptide 1 and 2 Receptors Genes","volume":"49","author":"Iacobellis","year":"2017","journal-title":"Horm. Metab. Res."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3892\/ijmm.2013.1350","article-title":"Glucagon-like peptide 1 regulates adipogenesis in 3T3-L1 preadipocytes","volume":"31","author":"Yang","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.2337\/db14-0302","article-title":"GLP-1 Agonism Stimulates Brown Adipose Tissue Thermogenesis and Browning through Hypothalamic AMPK","volume":"63","author":"Beiroa","year":"2014","journal-title":"Diabetes"},{"key":"ref_226","first-page":"448","article-title":"Effect of sitagliptin on epicardial fat thickness in subjects with type 2 diabetes and obesity: A pilot study","volume":"51","author":"Paoli","year":"2015","journal-title":"Endocrine"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12933-017-0648-x","article-title":"Have dipeptidyl peptidase-4 inhibitors ameliorated the vascular complications of type 2 diabetes in large-scale trials? The potential confounding effect of stem-cell chemokines","volume":"17","author":"Packer","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.bbrc.2016.09.158","article-title":"Blocking CXCR7-mediated adipose tissue macrophages chemotaxis attenuates insulin resistance and inflammation in obesity","volume":"479","author":"Peng","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2337\/db15-1224","article-title":"Inhibition of Dipeptidyl Peptidase-4 Impairs Ventricular Function and Promotes Cardiac Fibrosis in High Fat\u2013Fed Diabetic Mice","volume":"65","author":"Mulvihill","year":"2015","journal-title":"Diabetes"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000348756","article-title":"DPP-4 Inhibitors as Therapeutic Modulators of Immune Cell Function and Associated Cardiovascular and Renal Insulin Resistance in Obesity and Diabetes","volume":"3","author":"Aroor","year":"2013","journal-title":"Cardiorenal Med."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1161\/CIRCULATIONAHA.111.041418","article-title":"Long-Term Dipeptidyl-Peptidase 4 Inhibition Reduces Atherosclerosis and Inflammation via Effects on Monocyte Recruitment and Chemotaxis","volume":"124","author":"Shah","year":"2011","journal-title":"Circulation"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/med.21513","article-title":"Mechanisms and pathways of anti-inflammatory activity of DPP-4 inhibitors in cardiovascular and renal protection","volume":"39","author":"Lazarevic","year":"2019","journal-title":"Med. Res. Rev."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/dmrr.2437","article-title":"Efficacy of alogliptin, a dipeptidyl peptidase-4 inhibitor, on glucose parameters, the activity of the advanced glycation end product (AGE)\u2014receptor for AGE (RAGE) axis and albuminuria in Japanese type 2 diabetes","volume":"29","author":"Sakata","year":"2013","journal-title":"Diabetes\/Metabolism Res. Rev."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2147\/JIR.S221761","article-title":"Linagliptin Inhibits Lipopolysaccharide-Induced Inflammation Concentration-Dependently And -Independently","volume":"ume 12","author":"Sato","year":"2019","journal-title":"J. Inflamm. Res."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1475-2840-12-125","article-title":"Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate\/insulin-like growth factor II receptor","volume":"12","author":"Ishibashi","year":"2013","journal-title":"Cardiovasc. Diabetologia"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","article-title":"Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: A secondary analysis from the CANTOS randomised controlled trial","volume":"391","author":"Ridker","year":"2018","journal-title":"Lancet"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/ard.60.8.729","article-title":"Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis","volume":"60","author":"Cutolo","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.amjcard.2011.06.054","article-title":"Systematic Review and Meta-Analysis of Methotrexate Use and Risk of Cardiovascular Disease","volume":"108","author":"Micha","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMoa1809798","article-title":"Low-Dose Methotrexate for the Prevention of Atherosclerotic Events","volume":"380","author":"Ridker","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in Patients with Chronic Coronary Disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N. Engl. J. Med."}],"container-title":["Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-7737\/11\/3\/355\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:26:12Z","timestamp":1760135172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-7737\/11\/3\/355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,23]]},"references-count":243,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["biology11030355"],"URL":"https:\/\/doi.org\/10.3390\/biology11030355","relation":{},"ISSN":["2079-7737"],"issn-type":[{"value":"2079-7737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,23]]}}}